All News #Library
Sciences
First Patient Dosed In Immutep’s Ph III NSCLC Trial
25 Mar 2025 //
GLOBENEWSWIRE
Immutep Signs License Agreement with Cardiff University for Next-Gen Cancer Drug
26 Jun 2024 //
BIOSPECTRUM ASIA
Immutep Signs Exclusive License Agreement for Next-Gen Anti-LAG-3 Molecules
25 Jun 2024 //
GLOBENEWSWIRE
Immutep to Present TACTI-002 Interim Data at German Cancer Congress
04 Feb 2020 //
GLOBENEWSWIRE

Market Place
Sourcing Support